Q2 2025 · 13F-HR
22NW, LPholdings as filed
Filed 2025-08-14 · accession 0001214659-25-012016
$158.8M
Reported value
21
Positions
2025-06-30
Period end
The Brief · 22NW, LP · Q2 2025
AI · grounded in 13F
22NW, LP established a new position in FSTR worth $28.7M. The fund also initiated new stakes in LFCR for $22.6M and ANEB for $22.3M. Additional new positions include SRI at $13.7M and DHX at $9.8M. The fund ended the period with 21 positions and total AUM of $158.8M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 350060109 | FSTR | FOSTER L B CO | $28.7M | 18.1% | 1,313,121 | Common | SOLE |
| 514766104 | LFCR | LIFECORE BIOMEDICAL INC | $22.6M | 14.2% | 264,180 | Common | SOLE |
| 034569103 | ANEB | ANEBULO PHARMACEUTICALS INC | $22.3M | 14.0% | 15,467,300 | Common | SOLE |
| 86183P102 | SRI | STONERIDGE INC | $13.7M | 8.62% | 1,943,508 | Common | SOLE |
| 23331S100 | DHX | DHI GROUP INC | $9.8M | 6.17% | 3,299,937 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $7.6M | 4.78% | 923,679 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $7.6M | 4.77% | 560,042 | Common | SOLE |
| 230215105 | CULP | CULP INC | $7.3M | 4.60% | 1,859,061 | Common | SOLE |
| 71742W103 | PFX | PHENIXFIN CORP | $6.0M | 3.76% | 117,885 | Common | SOLE |
| 904677200 | UFI | UNIFI INC | $5.1M | 3.23% | 981,535 | Common | SOLE |
| G59665102 | MGTX | MEIRAGTX HLDGS PLC | $3.8M | 2.41% | 586,519 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $3.8M | 2.38% | 146,115 | Common | SOLE |
| 218683100 | CMT | CORE MOLDING TECHNOLOGIES IN | $3.2M | 2.00% | 191,222 | Common | SOLE |
| 878155308 | TISI | TEAM INC | $3.1M | 1.96% | 171,090 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $3.0M | 1.92% | 413,533 | Common | SOLE |
| 307675108 | FB1 | FARMER BROS CO | $2.7M | 1.69% | 1,955,526 | Common | SOLE |
| 578605107 | MEC | MAYVILLE ENGR CO INC | $2.5M | 1.56% | 155,450 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $2.5M | 1.56% | 882,844 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $1.7M | 1.09% | 636,364 | Common | SOLE |
| 86272A305 | SSKN | STRATA SKIN SCIENCES INC | $1.2M | 0.78% | 536,995 | Common | SOLE |
| 744375304 | — | PSYCHEMEDICS CORPORATION CMN | $618,316 | 0.39% | 276,034 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.